Medical Press Releases

First Procedures Performed in Florida by $CDIX Demonstrate Commitment to Best-in-Class Healthcare for Underserved Traumatic Injury Populations

NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) NRXP Also Reports Its Superior Preservative-Free IV Ketamine Now Submitted for FDA Abbreviated New Drug Application

NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) $NRXP; $750 Million Market for Suicidal Depression Market Awaits

Star Sleep & Wellness, a leading provider of comprehensive sleep disorder care, is proud to announce its expansion into Pearland, Texas at 2501 S Galveston Ave.

$NRXP Has Manufactured Multiple Commercial Lots of NRX-100 and KETAFREE™ with a Shelf Life of Three Years.

Analyst D. Boral Targets NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) $NRXP at $34 Per Share — Pioneering Breakthroughs in Treatment-Resistant Depression and Chronic Pain

H.C. Wainwright Initiates Coverage with $34 Price Target, Citing Paradigm Shift in Depression Treatment. NRx Pharmaceuticals (N A S D A Q: NRXP) $NRXP

QView Medical, the only company with FDA-approved artificial intelligence for breast ultrasound cancer detection, today announced a strategic partnership with Eve Wellness, the first company to offer direct-to-consumer breast cancer screening.

New iPhone app makes it easy to set schedules, get reminders, log doses, and keep notes for dogs and cats. Learn more at PillPaw.com and download on the App Store.

IEI Technology today announced the HTB-300-MTL-H, a next-generation, medical-grade AI embedded system designed for space-constrained healthcare environments.

First Procedures Performed in Florida by $CDIX Demonstrate Commitment to Best-in-Class Healthcare for Underserved Traumatic Injury Populations

NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) NRXP Also Reports Its Superior Preservative-Free IV Ketamine Now Submitted for FDA Abbreviated New Drug Application

NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) $NRXP; $750 Million Market for Suicidal Depression Market Awaits

Star Sleep & Wellness, a leading provider of comprehensive sleep disorder care, is proud to announce its expansion into Pearland, Texas at 2501 S Galveston Ave.

A consortium lead by SageTech Medical, a pioneering UK-based company developing sustainable technologies for the healthcare sector, has been awarded £3.6 million in grant funding through Innovate UK's Grand Challenge.

Still deciding between joining Yoga classes in Boisar or signing up at a gym in Boisar? You're not alone. Many beginners feel confused about where to start — the calming world of yoga or the high-energy environment of the gym.

$NRXP Has Manufactured Multiple Commercial Lots of NRX-100 and KETAFREE™ with a Shelf Life of Three Years.

Professional consultations: breaking time and space constraints Since its official launch, lowe99.com has successfully handled over 100,000 online consultations and prescription deliveries, achieving an impressive platform satisfaction rate of 98%.

Analyst D. Boral Targets NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) $NRXP at $34 Per Share — Pioneering Breakthroughs in Treatment-Resistant Depression and Chronic Pain

H.C. Wainwright Initiates Coverage with $34 Price Target, Citing Paradigm Shift in Depression Treatment. NRx Pharmaceuticals (N A S D A Q: NRXP) $NRXP

QView Medical, the only company with FDA-approved artificial intelligence for breast ultrasound cancer detection, today announced a strategic partnership with Eve Wellness, the first company to offer direct-to-consumer breast cancer screening.

Attn:Health & Medical Editors: For Health Literacy Month: Along the lines of Health "Literacy," check out a book of Medical & Health-Related poems called "Crazy Robert's Medical and Health-Related Poems and Potential Song Lyrics."

NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) $NRXP Refiles Abbreviated New Drug Application; $40 Price Target in New H. C. Wainright Research Report

NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) $NRXP Suitability Petition is required for shift from multidose packaging of ketamine to single-patient dose preservative free ketamine

Boisar is buzzing with new restaurants, cafés, and food outlets, making it harder than ever to resist cravings while on a strict diet. Whether it's cheesy pizza or a decadent dessert, everyone faces the temptation of breaking their routine.

NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) $NRXP Continues Expansion with Completion of Dura Medical Acquisition in Network of Interventional Psychiatry Clinics

Pregnancy is a crucial journey that requires regular health checkups and reliable diagnostic support.

Firm Retains Black Dog Venture Partners as its strategic Advisor

In the pharmaceutical and analytical chemistry sectors, maintaining the highest standards of accuracy is non-negotiable.

Patient Fairness empowers consumers to prevent, remove, and dispute unfair medical debt reporting.

NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) $NRXP Sees 10-Fold Market Expansion to 13 Million Americans for Bipolar Depression Alone.

Eating Disorder Treatment Centers of Louisiana offers women a new path to healing.

NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) $NRXP Has $7.8 Million for Clinic Acquisitions and Purchase of Kadima Neuropsychiatry Institute as Treatment Model and Leading Investigative Site for Suicidal Depression / PTSD

In the pharmaceutical industry, product safety and regulatory compliance hinge on rigorous impurity control.

NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) $NRXP Has $7.8 Million for Clinic Acquisitions and Purchase of Kadima Neuropsychiatry Institute as Treatment Model and Leading Investigative Site for Suicidal Depression / PTSD

In the evolving landscape of pharmaceutical research, the need for precise impurity profiling of plant-derived compounds has never been greater.

NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) $NRXP Has $7.8 Million for Clinic Acquisitions, Purchase of Kadima Neuropsychiatry Institute as Treatment Model and Leading Investigative Site for Suicidal Depression / PTSD

Maywell Health welcomes Dr. Tariq AlFarra, DO—a Johns Hopkins-trained pain specialist—expanding its expert team and commitment to evidence-based, minimally invasive, whole-person pain care.

In the evolving landscape of pharmaceutical R&D and regulatory compliance, access to high-quality impurity reference standards is non-negotiable.